Akovaz Side Effects

Generic name: ephedrine

Medically reviewed by Drugs.com. Last updated on May 5, 2023.

Note: This document contains side effect information about ephedrine. Some dosage forms listed on this page may not apply to the brand name Akovaz.

Applies to ephedrine: oral fixed-dose combination with guaifenesin, parenteral injection.

Side effects include:

Parenteral ephedrine (the active ingredient contained in Akovaz) Nervousness, insomnia, vertigo, headache, tachycardia, palpitation, sweating, nausea, vomiting, anorexia, vesical sphincter spasm (resulting in difficult and painful urination), urinary retention (particularly in males with prostatism).

For Healthcare Professionals

Applies to ephedrine: compounding powder, injectable solution, intravenous solution, oral capsule, oral tablet.

General

The most frequently reported side effects were nausea, vomiting, and tachycardia.^[Ref]

Cardiovascular

Very rare (less than 0.01%): Myocardial infarction

Frequency not reported: Tachycardia, palpitations, reactive hypertension, bradycardia, ventricular ectopics, R-R variability, pallor, angina/anginal pain, hypertension, hypotension, extrasystole, arrhythmias, vasodilation with low blood pressure, flushing, impaired circulation to extremities^[Ref]

Genitourinary

Frequency not reported: Difficult/painful urination, acute urinary retention^[Ref]

Nervous system

Frequency not reported: Dizziness, headache, trembling, lightheadedness, tremor, sedation^[Ref]

Respiratory

Frequency not reported: Dry nose, dry throat, shortness of breath, respiratory difficulty, dyspnea, respiratory depression^[Ref]

Psychiatric

Frequency not reported: Restlessness, addiction, nervousness, anxiety, insomnia, mood/mental changes, fear, irritability, confusion, delirium, euphoria, psychotic states, tension, hallucinations^[Ref]

Other

Frequency not reported: Fever, precordial pain, vertigo, tachyphylaxis, drug tolerance, drug dependence, weakness^[Ref]

Gastrointestinal

Frequency not reported: Nausea, vomiting, dry mouth, mild epigastric distress, hypersalivation^[Ref]

Metabolic

Frequency not reported: Hyperglycemia, anorexia^[Ref]

Dermatologic

Frequency not reported: Sweating^[Ref]

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer